Elevated Cell Wall Chitin in Candida albicans Confers Echinocandin Resistance In Vivo

Keunsook K. Lee, Donna M Maccallum, Mette D Jacobsen, Louise A Walker, Frank C Odds, Neil A R Gow, Carol A Munro

Research output: Contribution to journalArticle

98 Citations (Scopus)

Abstract

Candida albicans cells with increased cell wall chitin have reduced echinocandin susceptibility in vitro. The aim of this study was to investigate whether C. albicans cells with elevated chitin levels have reduced echinocandin susceptibility in vivo. BALB/c mice were infected with C. albicans cells with normal chitin levels and compared to mice infected with high-chitin cells. Caspofungin therapy was initiated at 24 h postinfection. Mice infected with chitin-normal cells were successfully treated with caspofungin, as indicated by reduced kidney fungal burdens, reduced weight loss, and decreased C. albicans density in kidney lesions. In contrast, mice infected with high-chitin C. albicans cells were less susceptible to caspofungin, as they had higher kidney fungal burdens and greater weight loss during early infection. Cells recovered from mouse kidneys at 24 h postinfection with high-chitin cells had 1.6-fold higher chitin levels than cells from mice infected with chitin-normal cells and maintained a significantly reduced susceptibility to caspofungin when tested in vitro. At 48 h postinfection, caspofungin treatment induced a further increase in chitin content of C. albicans cells harvested from kidneys compared to saline treatment. Some of the recovered clones had acquired, at a low frequency, a point mutation in FKS1 resulting in a S645Y amino acid substitution, a mutation known to confer echinocandin resistance. This occurred even in cells that had not been exposed to caspofungin. Our results suggest that the efficacy of caspofungin against C. albicans was reduced in vivo due to either elevation of chitin levels in the cell wall or acquisition of FKS1 point mutations.

Original languageEnglish
Pages (from-to)208-217
Number of pages10
JournalAntimicrobial Agents and Chemotherapy
Volume56
Issue number1
Early online date10 Oct 2011
DOIs
Publication statusPublished - Jan 2012

Fingerprint

Echinocandins
Chitin
caspofungin
Candida albicans
Cell Wall
Kidney
Point Mutation
Weight Loss
Amino Acid Substitution

Keywords

  • Amino Acid Substitution
  • Animals
  • Antifungal Agents
  • Candida albicans
  • Candidiasis
  • Cell Wall
  • Chitin
  • DNA Mutational Analysis
  • Drug Resistance, Fungal
  • Echinocandins
  • Female
  • Fungal Proteins
  • Glucosyltransferases
  • Kidney
  • Mice
  • Mice, Inbred BALB C
  • Microbial Sensitivity Tests
  • Microscopy, Fluorescence
  • Mutation
  • Survival Rate

Cite this

Elevated Cell Wall Chitin in Candida albicans Confers Echinocandin Resistance In Vivo. / Lee, Keunsook K.; Maccallum, Donna M; Jacobsen, Mette D; Walker, Louise A; Odds, Frank C; Gow, Neil A R; Munro, Carol A.

In: Antimicrobial Agents and Chemotherapy, Vol. 56, No. 1, 01.2012, p. 208-217.

Research output: Contribution to journalArticle

Lee, Keunsook K. ; Maccallum, Donna M ; Jacobsen, Mette D ; Walker, Louise A ; Odds, Frank C ; Gow, Neil A R ; Munro, Carol A. / Elevated Cell Wall Chitin in Candida albicans Confers Echinocandin Resistance In Vivo. In: Antimicrobial Agents and Chemotherapy. 2012 ; Vol. 56, No. 1. pp. 208-217.
@article{f0b80abd8feb4f8a8dd9c1d0bbb56cf8,
title = "Elevated Cell Wall Chitin in Candida albicans Confers Echinocandin Resistance In Vivo",
abstract = "Candida albicans cells with increased cell wall chitin have reduced echinocandin susceptibility in vitro. The aim of this study was to investigate whether C. albicans cells with elevated chitin levels have reduced echinocandin susceptibility in vivo. BALB/c mice were infected with C. albicans cells with normal chitin levels and compared to mice infected with high-chitin cells. Caspofungin therapy was initiated at 24 h postinfection. Mice infected with chitin-normal cells were successfully treated with caspofungin, as indicated by reduced kidney fungal burdens, reduced weight loss, and decreased C. albicans density in kidney lesions. In contrast, mice infected with high-chitin C. albicans cells were less susceptible to caspofungin, as they had higher kidney fungal burdens and greater weight loss during early infection. Cells recovered from mouse kidneys at 24 h postinfection with high-chitin cells had 1.6-fold higher chitin levels than cells from mice infected with chitin-normal cells and maintained a significantly reduced susceptibility to caspofungin when tested in vitro. At 48 h postinfection, caspofungin treatment induced a further increase in chitin content of C. albicans cells harvested from kidneys compared to saline treatment. Some of the recovered clones had acquired, at a low frequency, a point mutation in FKS1 resulting in a S645Y amino acid substitution, a mutation known to confer echinocandin resistance. This occurred even in cells that had not been exposed to caspofungin. Our results suggest that the efficacy of caspofungin against C. albicans was reduced in vivo due to either elevation of chitin levels in the cell wall or acquisition of FKS1 point mutations.",
keywords = "Amino Acid Substitution, Animals, Antifungal Agents, Candida albicans, Candidiasis, Cell Wall, Chitin, DNA Mutational Analysis, Drug Resistance, Fungal, Echinocandins, Female, Fungal Proteins, Glucosyltransferases, Kidney, Mice, Mice, Inbred BALB C, Microbial Sensitivity Tests, Microscopy, Fluorescence, Mutation, Survival Rate",
author = "Lee, {Keunsook K.} and Maccallum, {Donna M} and Jacobsen, {Mette D} and Walker, {Louise A} and Odds, {Frank C} and Gow, {Neil A R} and Munro, {Carol A}",
note = "PMID: 21986821 [PubMed - indexed for MEDLINE] PMCID: PMC3256049 Free PMC Article We thank Gillian Milne from the University of Aberdeen EM and histology facility and Luis Castillo for assistance with the histological analysis. We thank Cameron Douglas for helpful comments on the manuscript. We also thank Gilead Sciences Ltd. (Cambridge, United Kingdom), the Wellcome Trust (080088 and 086827), and the EC (ALLFUN and Ariadne) consortia for financial support and Merck Research Laboratories (NJ) for provision of caspofungin.",
year = "2012",
month = "1",
doi = "10.1128/AAC.00683-11",
language = "English",
volume = "56",
pages = "208--217",
journal = "Antimicrobial Agents and Chemotherapy",
issn = "0066-4804",
publisher = "AMER SOC MICROBIOLOGY",
number = "1",

}

TY - JOUR

T1 - Elevated Cell Wall Chitin in Candida albicans Confers Echinocandin Resistance In Vivo

AU - Lee, Keunsook K.

AU - Maccallum, Donna M

AU - Jacobsen, Mette D

AU - Walker, Louise A

AU - Odds, Frank C

AU - Gow, Neil A R

AU - Munro, Carol A

N1 - PMID: 21986821 [PubMed - indexed for MEDLINE] PMCID: PMC3256049 Free PMC Article We thank Gillian Milne from the University of Aberdeen EM and histology facility and Luis Castillo for assistance with the histological analysis. We thank Cameron Douglas for helpful comments on the manuscript. We also thank Gilead Sciences Ltd. (Cambridge, United Kingdom), the Wellcome Trust (080088 and 086827), and the EC (ALLFUN and Ariadne) consortia for financial support and Merck Research Laboratories (NJ) for provision of caspofungin.

PY - 2012/1

Y1 - 2012/1

N2 - Candida albicans cells with increased cell wall chitin have reduced echinocandin susceptibility in vitro. The aim of this study was to investigate whether C. albicans cells with elevated chitin levels have reduced echinocandin susceptibility in vivo. BALB/c mice were infected with C. albicans cells with normal chitin levels and compared to mice infected with high-chitin cells. Caspofungin therapy was initiated at 24 h postinfection. Mice infected with chitin-normal cells were successfully treated with caspofungin, as indicated by reduced kidney fungal burdens, reduced weight loss, and decreased C. albicans density in kidney lesions. In contrast, mice infected with high-chitin C. albicans cells were less susceptible to caspofungin, as they had higher kidney fungal burdens and greater weight loss during early infection. Cells recovered from mouse kidneys at 24 h postinfection with high-chitin cells had 1.6-fold higher chitin levels than cells from mice infected with chitin-normal cells and maintained a significantly reduced susceptibility to caspofungin when tested in vitro. At 48 h postinfection, caspofungin treatment induced a further increase in chitin content of C. albicans cells harvested from kidneys compared to saline treatment. Some of the recovered clones had acquired, at a low frequency, a point mutation in FKS1 resulting in a S645Y amino acid substitution, a mutation known to confer echinocandin resistance. This occurred even in cells that had not been exposed to caspofungin. Our results suggest that the efficacy of caspofungin against C. albicans was reduced in vivo due to either elevation of chitin levels in the cell wall or acquisition of FKS1 point mutations.

AB - Candida albicans cells with increased cell wall chitin have reduced echinocandin susceptibility in vitro. The aim of this study was to investigate whether C. albicans cells with elevated chitin levels have reduced echinocandin susceptibility in vivo. BALB/c mice were infected with C. albicans cells with normal chitin levels and compared to mice infected with high-chitin cells. Caspofungin therapy was initiated at 24 h postinfection. Mice infected with chitin-normal cells were successfully treated with caspofungin, as indicated by reduced kidney fungal burdens, reduced weight loss, and decreased C. albicans density in kidney lesions. In contrast, mice infected with high-chitin C. albicans cells were less susceptible to caspofungin, as they had higher kidney fungal burdens and greater weight loss during early infection. Cells recovered from mouse kidneys at 24 h postinfection with high-chitin cells had 1.6-fold higher chitin levels than cells from mice infected with chitin-normal cells and maintained a significantly reduced susceptibility to caspofungin when tested in vitro. At 48 h postinfection, caspofungin treatment induced a further increase in chitin content of C. albicans cells harvested from kidneys compared to saline treatment. Some of the recovered clones had acquired, at a low frequency, a point mutation in FKS1 resulting in a S645Y amino acid substitution, a mutation known to confer echinocandin resistance. This occurred even in cells that had not been exposed to caspofungin. Our results suggest that the efficacy of caspofungin against C. albicans was reduced in vivo due to either elevation of chitin levels in the cell wall or acquisition of FKS1 point mutations.

KW - Amino Acid Substitution

KW - Animals

KW - Antifungal Agents

KW - Candida albicans

KW - Candidiasis

KW - Cell Wall

KW - Chitin

KW - DNA Mutational Analysis

KW - Drug Resistance, Fungal

KW - Echinocandins

KW - Female

KW - Fungal Proteins

KW - Glucosyltransferases

KW - Kidney

KW - Mice

KW - Mice, Inbred BALB C

KW - Microbial Sensitivity Tests

KW - Microscopy, Fluorescence

KW - Mutation

KW - Survival Rate

U2 - 10.1128/AAC.00683-11

DO - 10.1128/AAC.00683-11

M3 - Article

VL - 56

SP - 208

EP - 217

JO - Antimicrobial Agents and Chemotherapy

JF - Antimicrobial Agents and Chemotherapy

SN - 0066-4804

IS - 1

ER -